Abstract

Prion diseases are characterized biochemically by protein aggregation of infectious prion isoforms (PrPSc), which result from the conformational conversion of physiological prion proteins (PrPC). PrPC are variable post-translationally modified glycoproteins, which exist as full length and as aminoterminally truncated glycosylated proteins and which exhibit differential detergent solubility. This implicates the presence of heterogeneous phenotypes, which overlap as protein complexes at the same molecular masses. Although the biological function of PrPC is still enigmatic, evidence reveals that PrPC exhibits metal-binding properties, which result in structural changes and decreased solubility. In this study, we analyzed the yield of PrPC metal binding affiliated with low solubility and changes in protein banding patterns. By implementing a high-speed centrifugation step, the interaction of zinc ions with PrPC was shown to generate large quantities of proteins with low solubility, consisting mainly of full-length glycosylated PrPC; whereas unglycosylated PrPC remained in the supernatants as well as truncated glycosylated proteins which lack of octarepeat sequence necessary for metal binding. This effect was considerably lower when PrPC interacted with copper ions; the presence of other metals tested exhibited no effect under these conditions. The binding of zinc and copper to PrPC demonstrated differentially soluble protein yields within distinct PrPC subtypes. PrPC–Zn2+-interaction may provide a means to differentiate glycosylated and unglycosylated subtypes and offers detailed analysis of metal-bound and metal-free protein conversion assays.

Highlights

  • Prion diseases are fatal neurodegenerative disorders characterized clinically by a long incubation period followed by a rapid course of disease, and biochemically by the accumulation of the infectious prion protein PrPSc

  • We exclusively used proteins with high solubility, the binding of zinc to PrPC induced a considerable shift of proteins into a PrPC isoform of low solubility retrievable in the pellet after high-speed centrifugation (Fig 1)

  • We found that ZnCl2 reduced PrPC solubility at concentrations as low as 50 to 100 μM, and insolubility rose as Zn2+ concentrations were increased

Read more

Summary

Introduction

Prion diseases are fatal neurodegenerative disorders characterized clinically by a long incubation period followed by a rapid course of disease, and biochemically by the accumulation of the infectious prion protein PrPSc. PrPSc originates from a host encoded prion protein (PrPC) by PLOS ONE | DOI:10.1371/journal.pone.0153931. As the mechanism of the folding of PrPSc is not yet clear, the conversion is associated with dramatic changes in biochemical and biophysical properties. PrPC is sensitive to proteolysis, is completely hydrolysed, and has high α-helix content [1]; whereas PrPSc demonstrates an increase of β-sheet structures [2] leading to hydrophobicity, the formation of fibrillar depositions and partial protease resistance. PrPC is posttranslationally modified by the formation of a glycophosphatidyl-inositol (GPI) anchor and a disulphide bond. Glycans attach to one or two asparagine residues yielding in di-, mono- and unglycosylated proteins [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call